New Points of Departure for More Global Influenza Vaccine Use

Abstract

Each year, influenza causes a significant acute respiratory disease burden. In addition, influenza pandemics periodically occur. Annual vaccination is the best tool for influenza prevention, but its effectiveness can vary from year to year. The narrow specificity of conventional vaccines and the drug resistance of currently circulating viruses reduce the effectiveness of prophylaxis and treatment and require the development of new broad-spectrum preparations. Furthermore, the challenge of creating a highly effective universal influenza vaccine takes on renewed intensity in the face of the COVID-19 pandemic.

Keywords

• influenza
• inactivated vaccines
• live attenuated vaccines
• next-generation vaccines
• synthetic vaccines
• cross protectivity